| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/29/2001 | WO2001090148A2 Neurotransmitter transporters |
| 11/29/2001 | WO2001090147A2 Long wavelength engineered fluorescent proteins |
| 11/29/2001 | WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 11/29/2001 | WO2001090135A1 Drug-amino acids sequence chimeric molecules |
| 11/29/2001 | WO2001090127A2 Haplotypes of the hoxd3 gene |
| 11/29/2001 | WO2001090126A2 Haplotypes of the snap29 gene |
| 11/29/2001 | WO2001090124A2 Haplotypes of the gpr31 gene |
| 11/29/2001 | WO2001090123A2 Haplotypes of the agtrl1 gene |
| 11/29/2001 | WO2001090120A2 Haplotypes of the evx1 gene |
| 11/29/2001 | WO2001090118A2 Haplotypes of the edn2 gene |
| 11/29/2001 | WO2001090117A2 Haplotypes of the p2ry1 gene |
| 11/29/2001 | WO2001090116A2 Haplotypes of the apobec2 gene |
| 11/29/2001 | WO2001090115A2 Haplotypes of the cdk4 gene |
| 11/29/2001 | WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene |
| 11/29/2001 | WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/29/2001 | WO2001089364A2 Hcv variants |
| 11/29/2001 | WO2001089303A1 Methods of modulating the activity of mura |
| 11/29/2001 | WO2001074405B1 Gene expression profiles in esophageal tissue |
| 11/29/2001 | WO2001055173A8 Nucleic acids, proteins, and antibodies |
| 11/29/2001 | WO2001051669A9 Nucleic acid binding assay and selection method |
| 11/29/2001 | WO2001044280A3 Methods and compositions for the manufacture of replication incompetent adenovirus |
| 11/29/2001 | WO2001043869A3 Cell arrays and the uses thereof |
| 11/29/2001 | WO2001043764A3 Methods for treating pervasive development disorders |
| 11/29/2001 | WO2001042471A8 Polypeptides and polynucleotides encoding same |
| 11/29/2001 | WO2001042446A3 A functional gene array in yeast |
| 11/29/2001 | WO2001040491A3 Udp-glucose:aglycon-glucosyltransferase |
| 11/29/2001 | WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it |
| 11/29/2001 | WO2001038566A3 Screening method for candidate drugs |
| 11/29/2001 | WO2001034806A3 Methods and compositions for screening using diphtheria toxin constructs |
| 11/29/2001 | WO2001033217A3 Monitoring the activity of factor xa inhibitors |
| 11/29/2001 | WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 11/29/2001 | WO2001029264A3 Nucleic acid primers and probes for detecting tumor cells |
| 11/29/2001 | WO2001029253A3 Simultaneous visualization of eu- and heterochromatin |
| 11/29/2001 | WO2001029234A3 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 11/29/2001 | WO2001029064A8 Melanoma antigens and methods of use |
| 11/29/2001 | WO2001028684A3 System and method for filling a substrate with a liquid sample |
| 11/29/2001 | WO2001025471A3 Method for the detection of antimicrobial residues |
| 11/29/2001 | WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 11/29/2001 | WO2001025246A3 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same |
| 11/29/2001 | WO2001023590A3 22196, a novel human aminopeptidase |
| 11/29/2001 | WO2001020029A3 Genetic markers of toxicity, preparation and uses thereof |
| 11/29/2001 | WO2001016357A3 Novel target for antiparasitic agents and inhibitors thereof |
| 11/29/2001 | WO2001006257A8 Metal nanoshells for biosensing applications |
| 11/29/2001 | WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors |
| 11/29/2001 | WO2001000826A3 Novel molecules of the card-related protein family and uses thereof |
| 11/29/2001 | WO2000073469A3 Protein kinases |
| 11/29/2001 | WO2000061597A9 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
| 11/29/2001 | WO2000043505A3 Protease with two aspartate radicals in the catalytically active structure |
| 11/29/2001 | WO2000040722A3 Insulin-synthesis genes |
| 11/29/2001 | US20010047526 Mapping molecular interactions in plants with protein fragments complementation assays |
| 11/29/2001 | US20010047080 Inhibits hiv infection of cells |
| 11/29/2001 | US20010047078 Methods for identifying inhibitors of methionine aminopeptidases |
| 11/29/2001 | US20010047077 Nucleic acid analogs with a chelating functionality |
| 11/29/2001 | US20010046714 Table for binding components of a sample, such as nucleic acids, comprising magnetic particles and an excipient that links the particles; useful in analysis of liquids |
| 11/29/2001 | US20010046707 Enhancing the competence of a cell through production of a library of recombinant genes |
| 11/29/2001 | US20010046706 Controlled electroporation and mass transfer across cell membranes |
| 11/29/2001 | US20010046700 Fluid control module and temperature controller |
| 11/29/2001 | US20010046699 Apparatus for positioning substances for detection and film for positioning substances for detection and manufacturing method of carrier for substances for detection |
| 11/29/2001 | US20010046694 1-deoxy-D-xylulose-5-phosphate reductoisomerases, and methods of use |
| 11/29/2001 | US20010046689 Processeing microscopic images to provide numerical data as an indicator |
| 11/29/2001 | US20010046688 Substrate of an oxidant, stabilizer and buffer with an extended shelf life is useful with enzyme based probes; detecting DNA fragments in DNA sequencing |
| 11/29/2001 | US20010046687 Stabilized by adding trehalose to its saturation solubility; microorganism detection for cleanliness of food preparation areas |
| 11/29/2001 | US20010046682 Presence of a target reactant is determined by measuring the amount of material bound to an immobilized reactant |
| 11/29/2001 | US20010046681 Shot-gun sequencing and amplification without cloning |
| 11/29/2001 | US20010046679 Site-selective nucleic acid modification with redox active transition metal complexes |
| 11/29/2001 | US20010046678 Dissociating a solution of double stranded nucleic acid into single strands to measure UV absorption and acquiring a thermal melting profile |
| 11/29/2001 | US20010046677 Method for detecting mutations in nucleic acids |
| 11/29/2001 | US20010046676 Integrated sequencing device |
| 11/29/2001 | US20010046674 Upon binding a ligand to a signal generated by a reporter molecule, detecting and quantifying the ligand in solution |
| 11/29/2001 | US20010046673 Illuminating a nucleic acid sample, detecting light transmission and determining presence, absence, or identity of the target |
| 11/29/2001 | US20010046671 Hybridizing gene sequences from biological processes with probes and determining and identifying genes that are differentially expressed; contains only gene sequences of interest in a particular area |
| 11/29/2001 | US20010046670 Single stranded DNA sequence hybridizes an oligonucleotide or DNA analogue and then complexes with a marker; output signals are measured for formation and dissociation indications |
| 11/29/2001 | US20010046669 Genetically filtered shotgun sequencing of complex eukaryotic genomes |
| 11/29/2001 | US20010046668 Binding an anchor to a substrate with a fluorescent radical attached; virus detection |
| 11/29/2001 | US20010046667 Determination of latent HIV infection |
| 11/29/2001 | US20010046665 Method of identifying the function of a test agent |
| 11/29/2001 | US20010046663 A compound is attached to a solid support and enzyme binding is assessed with/without the presence of metal; modulation detection |
| 11/29/2001 | US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/29/2001 | US20010045359 Separation of cell particle by dielectrophoresis |
| 11/29/2001 | EP1144603A3 Protease |
| 11/29/2001 | DE10024174A1 Verfahren zum Selektieren von Inhibitoren für Enzyme A method of selecting inhibitors for enzymes |
| 11/29/2001 | DE10023743A1 Peptidsubstrate zur direkten Messung enzymatischer Aktivitäten Peptide substrates for the direct measurement of enzymatic activities |
| 11/29/2001 | CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/29/2001 | CA2429199A1 Drug metabolizing enzymes |
| 11/29/2001 | CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
| 11/29/2001 | CA2410317A1 Methods for assaying gene imprinting and methylated cpg islands |
| 11/29/2001 | CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 11/29/2001 | CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 11/29/2001 | CA2410094A1 Compositions and methods for modulating tumor specific expression |
| 11/29/2001 | CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods |
| 11/29/2001 | CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 11/29/2001 | CA2409873A1 Hcv variants |
| 11/29/2001 | CA2409774A1 Methods for genetic analysis of dna to detect sequence variances |
| 11/29/2001 | CA2409772A1 Antiviral therapy |
| 11/29/2001 | CA2409309A1 Materials and methods for detection of nucleic acids |
| 11/29/2001 | CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/29/2001 | CA2408749A1 Drug screening systems and assays |
| 11/29/2001 | CA2408743A1 Method of detecting inflammatory lung disorders |
| 11/29/2001 | CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses |
| 11/29/2001 | CA2408728A1 Compositions and methods for nucleic acid or polypeptide analyses |